We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
Article purchase
Temporarily unavailable
References
1
Korkmaz, S, Gülşen, SÇ., Tatlı, S, Aytaç, E, Kılıç, N, Kaya, Ş.Leukoencephalopathy after excessive cannabinoid use. Prim Care Companion CNS Disord. 2023;25:23cr03525.CrossRefGoogle ScholarPubMed
2
Yücel, M, Solowij, N, Respondek, C, et al.Regional brain abnormalities associated with long-term heavy cannabis use. Arch Gen Psychiatry. 2008;65:694–701.CrossRefGoogle ScholarPubMed
3
Dalmau, J, Graus, F, Villarejo, A, et al.Clinical analysis of anti-Ma2-associated encephalitis. Brain. 2004;127:1831–44.CrossRefGoogle ScholarPubMed
4
Ortega Suero, G, Sola-Valls, N, Escudero, D, Saiz, A, Graus, F.Anti-Ma and anti-Ma2-associated paraneoplastic neurological syndromes. Neurologia (Engl Ed). 2018;33:18–27.CrossRefGoogle ScholarPubMed
5
Hoffmann, LA, Jarius, S, Pellkofer, HL, et al.Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases. J Neurol Neurosurg Psychiatry. 2008;79:767–73. DOI: 10.1136/jnnp.2007.118588.CrossRefGoogle ScholarPubMed